GeneDx (WGS) PT Raised to $155 at Wells Fargo
Tweet
Share
E-mailGet Alerts WGS Hot Sheet
Price: $79.15 -3.93%
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 3
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 3
Join SI Premium – FREE
Wells Fargo analyst Brandon Couillard raised the price target on GeneDx (NASDAQ: WGS) to $155.00 (from $140.00) while maintaining a Equal Weight rating.
You May Also Be Interested In
- Goldman Sachs Downgrades Douglas AG (DOU:GR) to Sell
- Shurgard Self Storage SA (SHUR:BB) PT Lowered to EUR29 at Morgan Stanley
- JPMorgan Downgrades HomeCo Daily Needs REIT (HDN:AU) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
